This content is machine translated Multiple sclerosis Limits, hurdles and solutions in the management of the disease Each year, the Forum of the Americas Committee for Treatment and Research in Multiple Sclerosis explores the dynamic environment of the disease in a unique series of scientific and clinical...…
View Post 6 min This content is machine translated Neuroimmunology Multiple sclerosis and NMOSD: background and developments Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are both diseases of the central nervous system. They can have similar symptoms and for a long time NMOSD was regarded...…
View Post 4 min This content is machine translated Multiple sclerosis Effective treatment options developed further In most cases, multiple sclerosis is relapsing-remitting and can progress to a chronic progressive stage over time. Which therapy management is used depends on the individual circumstances as well as...…
View Post 7 min This content is machine translated Multiple sclerosis Focus on genetic processes, early diagnostics and differential diagnoses Despite the difficult times that have existed in recent years, both the treatment and the journey of people living with and affected by MS have continued to evolve. New data...…
View Post 5 min This content is machine translated Nervous system Brain and artificial intelligence – an unbeatable double?! The theme of the annual meeting of the European Society of Neurology was ” Neurology beyond Big Data”. Digitalization has long since found its way into medicine. Ever larger volumes...…
View Post 11 min This content is machine translated Neuroscience Current highlights, innovative findings, exciting results “The Quintessence of Neuroscience for the 21st Century” was the theme of the American Academy of Neurology ‘s anniversary meeting – and the range of topics lived up to that...…
View Post 3 min This content is machine translated Multiple sclerosis RAW, PIRA and the disability progression – an overview. Patients with multiple sclerosis acquire disability either through relapse-associated deterioration (RAW) or relapse-independent progression (PIRA). One study now addressed the questions of how early progression begins in the course of...…
View Post 4 min This content is machine translated Brain (nerve) diseases Recognizing deficits in vestibular paroxysmia, multiple sclerosis and co. The central nervous system is permanently exposed to a variety of challenges. Some hurdles can be overcome; others require help. Researchers are working at full speed to decipher processes in...…
View Post 3 min This content is machine translated Multiple Sclerosis: RRMS Therapy change – strategy for follow-up treatment Until the individually appropriate disease-modifying therapy (DMT) is available, there arein the absence of predictive biomarkers, stepwise optimizations are often necessary, possibly resulting in multiple changes of DMT. To reduce...…
View Post 6 min This content is machine translated Multiple sclerosis Therapy, pathogenesis and clinic of the heterogeneous disease in view The world’s largest congress dedicated to research on the pathogenesis, diagnosis and treatment of multiple sclerosis and related neurological disorders, ECTRIMS, once again brought together renowned experts in MS research,...…